Jadwal Sholat

Memuat jadwal sholat…

Kedokteran & Kesehatan editorial

Open AccessOA2023

2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review

Prostate cancer remains the second most common cancer among men worldwide, with incidence highest in developed regions. Screening advances like MRI and biomarkers may reduce mortality but risk overdiagnosis; modifiable risk factors include smoking, diet, and occupational exposures.
O. Bergengren; K. Pekala; K. Matsoukas; J. Fainberg; S. Mungovan; O. Bratt; F. Bray; O. Brawley; A. Luckenbaugh; L. Mucci; T. Morgan; S. Carlsson· European Urology· 2023· DOI 10.1016/j.eururo.2023.04.021

The core problem

Prostate cancer (PCa) is a major global health burden, being the second most common cancer in men. Understanding its epidemiology and risk factors is crucial for improving prevention and early detection. This systematic review, published in *European Urology*, aims to summarize current evidence on descriptive epidemiology, large screening studies, diagnostic techniques, and risk factors for PCa. The review follows PRISMA guidelines and is registered in PROSPERO (CRD42022359728). The authors highlight the importance of identifying modifiable risk factors and optimizing screening strategies to reduce mortality while minimizing harms.

Innovation

The authors obtained PCa incidence and mortality rates for 2020 from the GLOBOCAN database of the International Agency for Research on Cancer. A systematic search was performed in July 2022 using PubMed/MEDLINE and EMBASE databases. The review adhered to PRISMA guidelines and was registered in PROSPERO. The evidence synthesis included descriptive epidemiology, screening studies, diagnostic techniques, and risk factors. The limitations note that evidence is derived from a meta-analysis of mostly retrospective studies.
Introduction
Prostate cancer (PCa) is a major global health burden, being the second most common cancer in men. Understanding its epidemiology and risk factors is crucial for improving prevention and early detection. This systematic review, published in *European Urology*, aims to summarize current evidence on descriptive epidemiology, large screening studies, diagnostic techniques, and risk factors for PCa. The review follows PRISMA guidelines and is registered in PROSPERO (CRD42022359728). The authors highlight the importance of identifying modifiable risk factors and optimizing screening strategies to reduce mortality while minimizing harms.

Why it matters

The authors conclude that PCa remains the second most common cancer among men worldwide. Screening is gaining acceptance and is expected to reduce mortality, but overdiagnosis and overtreatment are significant concerns. Increasing use of MRI and biomarkers may mitigate some negative consequences of screening by improving the detection of clinically significant cancers. Avoidable risk factors for PCa may include smoking, diet, physical activity, specific medications, and certain occupations. The patient summary emphasizes that improved diagnostic techniques can help reduce the number of men who need to be diagnosed and treated to save one life. The review underscores the need for balanced prevention and screening strategies.

Who should read this

Pembaca Research Digest dan praktisi rumpun ini.

Opening member content…